Matthew Fyfe

Head-Chemistry at TopiVert Ltd.

Matthew Fyfe

Matthew Fyfe

Head-Chemistry at TopiVert Ltd.

Biography

Dr. Matthew Fyfe is Head-Chemistry at TopiVert Ltd.Dr. Fyfe was previously employed as a Director-Drug Discovery by Oryzon Genomics SA, a Director-Medicinal Chemistry by OSI Pharmaceuticals, and a Member by Royal Society of Chemistry.He received his undergraduate degree from the University of Glasgow, a graduate degree from Columbia University, and a doctorate degree from the University of Birmingham.

Overview
RelSci Relationships

19

Relationships
RelSci Relationships are individuals Matthew Fyfe likely has professional access to. A relationship does not necessarily indicate a personal connection.

Chief Scientific Officer & Director at TopiVert Ltd.

Relationship likelihood: Strong

Founder at TopiVert Ltd.

Relationship likelihood: Average

Former Vice President-Commercial Operations at Circassia Pharmaceuticals Plc

Relationship likelihood: Average

Chief Financial Officer at Syncona Partners LLP

Relationship likelihood: Average

Former Chemistry Director at Piramed Ltd.

Relationship likelihood: Average

Chief Business Development Officer at Oryzon Genomics SA

Relationship likelihood: Average

Scientific Coordinator at Oncnosis Pharma AIE

Relationship likelihood: Weak

Chief Intellectual Property Officer at Oryzon Genomics SA

Relationship likelihood: Weak

Director at Oryzon Genomics Diagnóstico SL

Relationship likelihood: Weak

Director-Medicinal Chemistry at Pulmocide Ltd.

Relationship likelihood: Weak

In The News
Paths to Matthew Fyfe
Potential Connections via
Relationship Science
You
Matthew Fyfe
Head-Chemistry at TopiVert Ltd.
Education

Founded in 1451, Glasgow is the fourth-oldest university in the English-speaking world. Over the last five centuries and more, we’ve constantly worked to push the boundaries of what’s possible. We’ve fostered the talents of seven Nobel laureates, one Prime Minister and Scotland’s inaugural First Minister. We’ve welcomed Albert Einstein to give a lecture on the origins of the general theory of relativity. Scotland’s first female medical graduates completed their degrees here in 1894 and the world’s first ultrasound images of a foetus were published by Glasgow Professor Ian Donald in 1958. In 1840 we became the first university in the UK to appoint a Professor of Engineering, and in 1957, the first in Scotland to have an electronic computer. All of this means that if you choose to work or study here, you’ll be walking in the footsteps of some of the world’s most renowned innovators, from scientist Lord Kelvin and economist Adam Smith, to the pioneer of television John Logie Baird.

Birmingham has been challenging and developing great minds for more than a century. Characterised by a tradition of innovation, research at the University has broken new ground, pushed forward the boundaries of knowledge and made an impact on people’s lives. We continue this tradition today and have ambitions for a future that will embed our work and recognition of the Birmingham name on the international stage. Universities are never complete. They develop as new challenges and opportunities occur. At Birmingham we innovate, we push the frontiers of understanding; we ask new research questions, we turn theory through experiment into practice – because that’s what great universities do.

Columbia University is one of the world's most important centers of research and at the same time a distinctive and distinguished learning environment for undergraduates and graduate students in many scholarly and professional fields. The University recognizes the importance of its location in New York City and seeks to link its research and teaching to the vast resources of a great metropolis. It seeks to attract a diverse and international faculty and student body, to support research and teaching on global issues, and to create academic relationships with many countries and regions. It expects all areas of the university to advance knowledge and learning at the highest level and to convey the products of its efforts to the world.

Memberships
Member
Prior

The Royal Society of Chemistry is the world's leading chemistry community, advancing excellence in the chemical sciences. With 49,000 members and a worldwide knowledge business that spans the globe, we are the UK's professional body for chemical scientists; a not-for-profit organisation with 170 years of history and an international vision for the future. We promote, support and celebrate chemistry. We work to shape the future of the chemical sciences - for the benefit of science and humanity.

Career History
Head-Chemistry
2011 - Current

TopiVert Ltd. develops topical treatments for inflammatory diseases of the eye and gut. Its application is used in the treatment of asthma, chronic obstructive pulmonary disease, and cystic fibrosis and other inflammatory diseases of the lungs. The company was founded by Eric Charles Meldrum in 2011 and is headquartered in London, the United Kingdom.

Director-Drug Discovery
2010 - Prior

Oryzon Genomics SA engages in the discovery, research, and development of new chemical entities, as well as conducting clinical trials. It focuses on epigenetics in various therapeutic indications, with a special emphasis on oncology and neurodegenerative disease. The company was founded by Carlos Manuel Buesa Arjol and Tamara Maes on June 2, 2000 and is headquartered in Barcelona, Spain.

Director-Medicinal Chemistry
Prior
Other Affiliations
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Matthew Fyfe. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Matthew Fyfe's profile does not indicate a business or promotional relationship of any kind between RelSci and Matthew Fyfe.